Effects on Colesevelam HC1 (WelChol®) on Insulin Sensitivity in Subjects With Type 2 Diabetes Mellitus
Status:
Completed
Trial end date:
2007-03-01
Target enrollment:
Participant gender:
Summary
This study is designed to test whether WelChol (colesevelam HC1) improves blood sugar control
in patients with type 2 diabetes by making their own insulin work more efficiently.